Wouter J Schonewille Selected Research

Time-to-Treatment

1/2022	Improvements in Endovascular Treatment for Acute Ischemic Stroke: A Longitudinal Study in the MR CLEAN Registry.
7/2020	Interhospital transfer vs. direct presentation of patients with a large vessel occlusion not eligible for IV thrombolysis.
9/2019	Impact of single phase CT angiography collateral status on functional outcome over time: results from the MR CLEAN Registry.
5/2019	Response to Late-Window Endovascular Revascularization Is Associated With Collateral Status in Basilar Artery Occlusion.
1/2019	Effect of Interhospital Transfer on Endovascular Treatment for Acute Ischemic Stroke.
10/2016	Neurologic Examination at 24 to 48 Hours Predicts Functional Outcomes in Basilar Artery Occlusion Stroke.
8/2009	Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wouter J Schonewille Research Topics

Disease

27	Stroke (Strokes) 01/2022 - 08/2009
26	Ischemic Stroke 01/2022 - 01/2010
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 10/2015
3	Infarction (Infarctions) 12/2020 - 04/2016
3	Migraine Disorders (Migraine) 12/2019 - 12/2009
3	Thrombosis (Thrombus) 05/2019 - 01/2010
2	Edema (Dropsy) 12/2019 - 02/2009
1	Peripheral Arterial Disease 01/2020
1	Vascular Malformations 01/2018
1	Hemorrhage 01/2017
1	Hyperglycemia 01/2017
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 01/2017
1	Atherosclerosis 01/2014
1	Cerebral Hemorrhage 03/2013
1	Inflammation (Inflammations) 02/2009

Drug/Important Bio-Agent (IBA)

7	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2021 - 01/2010
3	Cytidine Triphosphate (CTP)IBA 12/2020 - 01/2015
1	2,6-dinitrotoluene (DNT)IBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2019
1	Biological ProductsIBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Anesthetics (Anesthetic Agents)IBA 08/2016
1	BilirubinIBA 05/2015
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	FibrinIBA 01/2014
1	MA 12 (MA12)IBA 12/2009
1	SteroidsIBA 02/2009

Therapy/Procedure

15	Therapeutics 02/2021 - 01/2010
11	Thrombectomy 01/2022 - 01/2010
7	Time-to-Treatment 01/2022 - 08/2009
2	Stents 01/2022 - 06/2017
1	Punctures 01/2022
1	Intravenous Administration 01/2019
1	Treatment Delay 01/2019
1	Catheters 01/2018
1	Aftercare (After-Treatment) 05/2017
1	Length of Stay 05/2017
1	General Anesthesia 05/2015
1	Anesthesia 05/2015
1	Contraindications 01/2010